Ad is loading...
AIIEX
Price
$22.86
Change
-$0.28 (-1.21%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

AIIEX vs RERAX

Header iconAIIEX vs RERAX Comparison
Open Charts AIIEX vs RERAXBanner chart's image
Invesco EQV International Equity A
Price$22.86
Change-$0.28 (-1.21%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
AIIEX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AIIEX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIIEX is a Sell and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. AIIEX (2.52B). RERAX pays higher dividends than AIIEX: RERAX (0.91) vs AIIEX (0.60). AIIEX was incepted earlier than RERAX: AIIEX (33 years) vs RERAX (22 years). RERAX is a more actively managed with annual turnover of: 34.00 vs. AIIEX (32.00). RERAX has a lower initial minimum investment than AIIEX: RERAX (250) vs AIIEX (1000). RERAX annual gain was more profitable for investors over the last year : 7.63 vs. AIIEX (6.67). RERAX return over 5 years is better than : 3.85 vs. AIIEX (-30.77).
AIIEXRERAXAIIEX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence33 years22 years-
Gain YTD0.1753.0526%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.52B129B2%
Annual Yield % from dividends0.600.9165%
Returns for 1 year6.677.6387%
Returns for 3 years-32.07-19.45165%
Returns for 5 years-30.773.85-799%
Returns for 10 years-27.2615.89-171%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics